Clinical trial
Applying Transcutaneous Auricular Vagus Nerve Stimulation to Treat Fibromyalgia
NCT04777500 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Applying Transcutaneous Auricular Vagus Nerve Stimulation to Treat Fibromyalgia
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- October 3, 2026
- Completion date
- March 31, 2027
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.